Asymptomatic Strongyloidiasis among Latin American Migrants in Spain: A Community-Based Approach

Strongyloides stercoralis infection is frequently underdiagnosed since many infections remain asymptomatic. Aim: To estimate the prevalence and characteristics of asymptomatic S. stercoralis infection in Latin American migrants attending a community-based screening program for Chagas disease in Spain. Methodology: Three community-based Chagas disease screening campaigns were performed in Alicante (Spain) in 2016, 2017, and 2018. Serological testing for S. stercoralis infection was performed using a non-automatized IVD-ELISA detecting IgG (DRG Instruments GmbH, Marburg, Germany). Results: Of the 616 migrants from Central and South America who were screened, 601 were included in the study: 100 children and adolescents (<18 years of age) and 501 adults. Among the younger group, 6 participants tested positive (prevalence 6%, 95% confidence interval [CI] 2.5% to 13.1%), while 60 adults did so (prevalence 12%, 95% CI 9.3% to 15.3%). S. stercoralis infection was more common in men than in women (odds ratio adjusted [ORa] 2.28, 95% CI 1.289 to 4.03) and in those from Bolivia (ORa 2.03, 95% CI 1.15 to 3.59). Prevalence increased with age (ORa 1.02, 95% CI 0.99 to 1.05). In contrast, a university education had a protective effect (ORa 0.29, 95% CI 0.31 to 0.88). Forty-one (41/66; 62.1%) of the total cases of S. stercoralis infection were treated at the health care center. Positive stool samples were observed in 19.5% of the followed-up positive cases. Conclusion: Incorporating serological screening for S. stercoralis into community-based screening for Chagas disease is a useful intervention to detect asymptomatic S. stercoralis infection in Central and South American migrants and an opportunity to tackle neglected tropical diseases in a transversal way. The remaining challenge is to achieve patients’ adherence to the medical follow-up.

[1]  Z. Bisoffi,et al.  Cost-effectiveness of different strategies for screening and treatment of Strongyloides stercoralis in migrants from endemic countries to the European Union , 2020, BMJ Global Health.

[2]  T. Vinuesa,et al.  Infection by Strongyloides stercoralis in immigrants with Chagas disease: evaluation of eosinophilia as screening method in primary care , 2019, Tropical medicine & international health : TM & IH.

[3]  W. Cevallos,et al.  Mapping the Prevalence of Strongyloides stercoralis Infection in Ecuador: A Serosurvey. , 2019, The American journal of tropical medicine and hygiene.

[4]  I. Molina,et al.  Strongyloidiasis screening in migrants living in Spain: systematic review and meta‐analysis , 2019, Tropical medicine & international health : TM & IH.

[5]  F. Salvador,et al.  High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study , 2019, bioRxiv.

[6]  S. Mas‐Coma,et al.  Strongyloidiasis in northern Vietnam: epidemiology, clinical characteristics and molecular diagnosis of the causal agent , 2019, Parasites & Vectors.

[7]  P. Chiodini,et al.  Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. , 2019, The Lancet. Infectious diseases.

[8]  F. Vazquez,et al.  USE OF SEROLOGY IN A SYSTEMATIC SCREENING PROGRAMME FOR STRONGYLOIDIASIS IN AN IMMIGRANT POPULATION. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[9]  S. Meymandi,et al.  Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States , 2019, PLoS neglected tropical diseases.

[10]  M. Cabada,et al.  Strongyloides stercoralis Infection at Different Altitudes of the Cusco Region in Peru. , 2019, The American journal of tropical medicine and hygiene.

[11]  E. Sulleiro,et al.  A Community-Based Intervention for the Detection of Chagas Disease in Barcelona, Spain , 2019, Journal of Community Health.

[12]  R. López-Vélez,et al.  Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017) , 2019, PLoS neglected tropical diseases.

[13]  A. Benito,et al.  Chagas screening and treatment among Bolivians living in Madrid, Spain: The need for an official protocol , 2019, PloS one.

[14]  T. Nutman,et al.  Strongyloidiasis: A Neglected Tropical Disease. , 2019, Infectious disease clinics of North America.

[15]  G. Schwarzer,et al.  Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. , 2019, The Lancet. Global health.

[16]  Ingrid Arevalo-Rodriguez,et al.  Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review , 2018, International journal of environmental research and public health.

[17]  R. López-Vélez,et al.  Community screening campaign for Strongyloides stercoralis among Latin American immigrants in Spain. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  S. Montgomery,et al.  Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations , 2018, Transplant infectious disease : an official journal of the Transplantation Society.

[19]  F. Gobbi,et al.  Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection—A systematic review and meta-analysis , 2018, PLoS neglected tropical diseases.

[20]  R. López-Vélez,et al.  Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America , 2018, Transplantation.

[21]  M. Díaz-Menéndez,et al.  Management of severe strongyloidiasis attended at reference centers in Spain , 2018, PLoS neglected tropical diseases.

[22]  F. Salvador,et al.  Surveillance of strongyloidiasis in Spanish in-patients (1998–2014) , 2017, PloS one.

[23]  S. Meymandi,et al.  A Community-Based Screening Program for Chagas Disease in the USA. , 2017, Trends in parasitology.

[24]  M. Abril,et al.  Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study , 2017, PLoS neglected tropical diseases.

[25]  S. Sauleda,et al.  Strongyloides stercoralis infection increases the likelihood to detect Trypanosoma cruzi DNA in peripheral blood in Chagas disease patients , 2017, Tropical medicine & international health : TM & IH.

[26]  R. López-Vélez,et al.  Hunting hidden parasites: Trypanosoma cruzi , 2017, The Lancet.

[27]  F. Formenti,et al.  A retrospective study comparing agar plate culture, indirect immunofluorescence and real-time PCR for the diagnosis of Strongyloides stercoralis infection , 2017, Parasitology.

[28]  M. Hoelscher,et al.  Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany , 2017, BMJ Open.

[29]  I. Molina,et al.  Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients , 2016, PLoS neglected tropical diseases.

[30]  R. Zachariah,et al.  Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area , 2015, PLoS neglected tropical diseases.

[31]  J. Saugar,et al.  Serological study of Trypanosoma cruzi, Strongyloides stercoralis, HIV, human T cell lymphotropic virus (HTLV) and syphilis infections in asymptomatic Latin-American immigrants in Spain. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  F. Formenti,et al.  Novel approaches to the diagnosis of Strongyloides stercoralis infection. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  T. Garate,et al.  Application of real-time PCR for the detection of Strongyloides spp. in clinical samples in a reference center in Spain. , 2015, Acta tropica.

[34]  T. Nutman,et al.  Accuracy of Five Serologic Tests for the Follow up of Strongyloides stercoralis Infection , 2015, PLoS neglected tropical diseases.

[35]  F. Gobbi,et al.  Prevalence of strongyloidiasis in Latin America: a systematic review of the literature , 2014, Epidemiology and Infection.

[36]  J. Saugar,et al.  Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia. , 2014, The American journal of tropical medicine and hygiene.

[37]  T. Nutman,et al.  Diagnostic Accuracy of Five Serologic Tests for Strongyloides stercoralis Infection , 2014, PLoS neglected tropical diseases.

[38]  P. Vounatsou,et al.  Strongyloides stercoralis: Global Distribution and Risk Factors , 2013, PLoS neglected tropical diseases.

[39]  P. Chiodini,et al.  The Laboratory Diagnosis and Follow Up of Strongyloidiasis: A Systematic Review , 2013, PLoS neglected tropical diseases.

[40]  Miriam Navarro,et al.  Chagas Disease in Spain: Need for Further Public Health Measures , 2012, PLoS neglected tropical diseases.

[41]  R. López-Vélez,et al.  A multidisciplinary approach to engage VFR migrants in Madrid, Spain. , 2012, Travel medicine and infectious disease.

[42]  J. Janik,et al.  Disseminated Strongyloides stercoralis Infection in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma , 2011, Acta Haematologica.

[43]  T. Nutman,et al.  Strongyloides stercoralis in the Immunocompromised Population , 2004, Clinical Microbiology Reviews.